Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $2.24 Million - $2.75 Million
-15,358 Reduced 50.76%
14,900 $2.58 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $4.28 Million - $5.17 Million
25,858 Added 587.68%
30,258 $5.12 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $287,736 - $380,171
-1,900 Reduced 30.16%
4,400 $868,000
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $384,421 - $443,371
2,300 Added 57.5%
6,300 $1.1 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $160,940 - $186,230
1,000 Added 33.33%
4,000 $688,000
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $1.83 Million - $2.21 Million
-12,600 Reduced 80.77%
3,000 $499,000
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $1.81 Million - $2.17 Million
-13,800 Reduced 46.94%
15,600 $2.29 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $1.22 Million - $1.5 Million
8,200 Added 38.68%
29,400 $4.36 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $967,014 - $1.24 Million
-6,200 Reduced 22.63%
21,200 $3.64 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $4.97 Million - $6.41 Million
27,400 New
27,400 $5.17 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $503,594 - $642,278
-2,600 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $492,154 - $545,194
-2,600 Reduced 50.0%
2,600 $505,000
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $639,190 - $770,759
4,100 Added 372.73%
5,200 $969,000
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $2.36 Million - $2.84 Million
-17,200 Reduced 93.99%
1,100 $182,000
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $1.95 Million - $2.24 Million
-30,800 Reduced 62.73%
18,300 $1.32 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $2.93 Million - $3.21 Million
49,100
49,100 $3.13 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.